Roxanne Metayer, O.D.
NPI 1609967470 · Optometrist · Windham, ME
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Roxanne Metayer, O.D. is a Optometrist provider in Windham, ME (NPI 1609967470).
Provider details
- NPI number
- 1609967470
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- O.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- OPT726 (ME)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,961 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Removal of Cataract With Insertion of Prosthetic Lens66984 | 1,655 | $1 |
| Established Patient Complete Exam of Visual System92014 | 181 | $123 |
| Established Patient Problem Focused Exam of Visual System92012 | 43 | $86 |
| Imaging of Retina92134 | 32 | $39 |
| Photography of the Retina92250 | 24 | $36 |
| New Patient Complete Exam of Visual System92004 | 14 | $147 |
| Exam of Visual Field With Extended Testing |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Erythromycin Basebrand: Erythromycin | 34 | 18 |
| Moxifloxacin Hclbrand: Moxifloxacin | 26 | 18 |
| Cyclosporinebrand: Restasis | 18 | — |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 17 | 15 |
| Azelastine Hcl | 15 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-09-27
- Last updated
- 2023-01-05
- Certified
- 2023-01-05
Frequently asked questions
- What is Roxanne Metayer's NPI number?
- Roxanne Metayer's National Provider Identifier (NPI) is 1609967470, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Roxanne Metayer's specialty?
- Roxanne Metayer is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
- Where is Roxanne Metayer located?
- Roxanne Metayer's practice location on file with NPPES is 4 Commons Ave # B, Windham, ME 04062-5554.
- What is Roxanne Metayer's phone number?
- The practice phone number listed in the NPPES registry for Roxanne Metayer is (207) 892-2273.
- Does Roxanne Metayer accept Medicare?
- Roxanne Metayer is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Roxanne Metayer's NPI active?
- Yes — Roxanne Metayer's NPI (1609967470) is active in the NPPES registry as of the last update on 2023-01-05.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.